Similar to our study, other studies found no significant change in weight or BMI in TCZ-treated non-diabetic RA patients over a period of three [23] or six months [24], or when patients were stratified to responders versus non-responders according to the DAS28-CRP criteria [25]. This evidence concerns the gene CRP and rheumatoid arthritis.